Stanozolol (Winstrol) 20mg by Astera Labs is a powerful oral anabolic steroid designed for cutting phases and performance enhancement. With low estrogenic risk and excellent muscle-hardening properties, it’s ideal for athletes and bodybuilders focused on fat loss, definition, and vascularity. Each sachet contains 100 tablets, dosed at 20mg per tab.
🔸 What Is Stanozolol 20mg (Winstrol) by Astera Labs?
Stanozolol, known by the brand name Winstrol, is a DHT-derived oral anabolic steroid favored for cutting cycles. The Astera Labs version offers high-quality pharmaceutical-grade tablets dosed at 20mg each, helping users retain lean muscle while burning fat and achieving a chiseled, vascular look.
Due to its strong anabolic and minimal estrogenic activity, Stanozolol doesn’t convert to estrogen, making it ideal for dry cycles with low water retention. It also boosts strength, speed, and power, making it popular in both aesthetic and performance sports.
✅ How to Use Stanozolol (Winstrol):
-
Recommended Daily Dose: 30–100mg
-
Standard Use: 40–50mg/day (split into 2 doses)
-
Advanced/Pre-contest Use: Up to 100mg/day
-
Cycle Length: 4–6 weeks (short cycles advised due to liver strain)
-
Administration: Once daily or split for stable blood levels
-
Liver Support: Recommended (e.g., TUDCA, NAC)
Suitable for use during a cutting cycle, alone or stacked with compounds like Anavar, Masteron, or Trenbolone.
✅ Side Effects & Precautions:
-
Low estrogenic risk: No water retention or gynecomastia
-
Possible side effects: Liver strain, joint dryness, cholesterol impact
-
Post-Cycle Therapy (PCT): Required after use to restore natural testosterone
-
Not suitable for women at standard doses due to virilization risks
✅ Product Authenticity – Astera Labs Code Verification:
All Astera Labs products come with a unique QR code for authenticity.
🔗 Check your product at: astera-shop.com/product-check
📱 Scan the QR code on the sachet or manually enter the code
🔒 Verify your purchase to ensure it’s 100% original





Reviews
There are no reviews yet.